Brooks DP[au] - Search Results

Year	Number of Results
1977	1
1978	2
1979	3
1980	1
1982	1
1983	4
1984	6
1985	7
1986	12
1987	3
1988	5
1989	9
1990	11
1991	10
1992	10
1993	8
1994	5
1995	8
1996	4
1997	4
1998	10
1999	9
2000	7
2001	8
2002	2
2003	2
2004	3
2005	4
2006	2
2007	7
2008	5
2014	1
2021	0

1

The pharmacology of fenoldopam.

Nichols AJ, Ruffolo RR Jr, Brooks DP. Nichols AJ, et al. Among authors: brooks dp. Am J Hypertens. 1990 Jun;3(6 Pt 2):116S-119S. doi: 10.1093/ajh/3.6.116s. Am J Hypertens. 1990. PMID: 1974439 Review.

2

Water and electrolyte homeostasis brings balance to physiology.

Pollock JS, Ryan MJ, Samson WK, Brooks DP. Pollock JS, et al. Among authors: brooks dp. Am J Physiol Regul Integr Comp Physiol. 2014 Sep 1;307(5):R481-3. doi: 10.1152/ajpregu.00246.2014. Epub 2014 Jul 16. Am J Physiol Regul Integr Comp Physiol. 2014. PMID: 25031231 Free article. Review.

3

Antioxidant activity of carvedilol in cardiovascular disease.

Dandona P, Ghanim H, Brooks DP. Dandona P, et al. Among authors: brooks dp. J Hypertens. 2007 Apr;25(4):731-41. doi: 10.1097/HJH.0b013e3280127948. J Hypertens. 2007. PMID: 17351362 Review.

4

Central adrenergic control of vasopressin release.

Brooks DP, Share L, Crofton JT. Brooks DP, et al. Neuroendocrinology. 1986;42(5):416-20. doi: 10.1159/000124480. Neuroendocrinology. 1986. PMID: 3703161

5

Molecular mechanisms of antidiuretic effect of oxytocin.

Li C, Wang W, Summer SN, Westfall TD, Brooks DP, Falk S, Schrier RW. Li C, et al. Among authors: brooks dp. J Am Soc Nephrol. 2008 Feb;19(2):225-32. doi: 10.1681/ASN.2007010029. Epub 2007 Dec 5. J Am Soc Nephrol. 2008. PMID: 18057218 Free PMC article.

6

The discovery of GSK221149A: a potent and selective oxytocin antagonist.

Liddle J, Allen MJ, Borthwick AD, Brooks DP, Davies DE, Edwards RM, Exall AM, Hamlett C, Irving WR, Mason AM, McCafferty GP, Nerozzi F, Peace S, Philp J, Pollard D, Pullen MA, Shabbir SS, Sollis SL, Westfall TD, Woollard PM, Wu C, Hickey DM. Liddle J, et al. Among authors: brooks dp. Bioorg Med Chem Lett. 2008 Jan 1;18(1):90-4. doi: 10.1016/j.bmcl.2007.11.008. Epub 2007 Nov 6. Bioorg Med Chem Lett. 2008. PMID: 18032036

7

Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.

Brooks DP, Ruffolo RR Jr. Brooks DP, et al. J Hypertens Suppl. 1999 Jun;17(2):S27-32. J Hypertens Suppl. 1999. PMID: 10465064 Review.

8

Carvedilol prevents and reverses hypertrophy-induced cardiac dysfunction.

Barone FC, Willette RN, Nelson AH, Ohlstein EH, Brooks DP, Coatney RW. Barone FC, et al. Among authors: brooks dp. Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4. Pharmacology. 2007. PMID: 17551266

9

Drug receptors and control of the cardiovascular system: recent advances.

Ruffolo RR Jr, Hieble JP, Brooks DP, Feuerstein GZ, Nichols AJ. Ruffolo RR Jr, et al. Among authors: brooks dp. Prog Drug Res. 1991;36:117-360. doi: 10.1007/978-3-0348-7136-5_4. Prog Drug Res. 1991. PMID: 1876708 Review. No abstract available.

10

Epithelin mRNA expression in polycystic kidney disease.

Ali SM, Nambi P, Fredrickson TA, Brooks DP. Ali SM, et al. Among authors: brooks dp. Peptides. 1999 Dec;20(12):1489-95. doi: 10.1016/s0196-9781(99)00160-6. Peptides. 1999. PMID: 10698125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results